GLOBAL THROMBECTOMY CATHETER MARKET

INTRODUCTION

A medical device called a thrombectomy catheter is used to dissolve blood clots (thrombi) from blood vessels, especially in situations when deep vein thrombosis (DVT) or acute vascular occlusion are present. Thrombectomy is the term for the process of removing clots with a thrombectomy catheter.

In order to aid the efficient removal of blood clots, the thrombectomy catheter normally consists of a long, flexible tube (catheter) with a number of design elements. 

Patients with acute arterial occlusions, such as those having a stroke brought on by a clot in the blood vessels of the brain (ischemic stroke) or those who have peripheral arterial occlusions in the limbs, frequently undergo thrombectomy. Deep vein thrombosis (DVT) in the lower extremities can also be treated with it. 

An interventional radiologist, interventional cardiologist, or vascular surgeon commonly performs the operation and inserts the thrombectomy catheter into the damaged blood vessel by a tiny puncture or incision.

The thrombus removal mechanism is then turned on to dislodge or remove the clot after the catheter has been guided to the location of the obstruction. The goals of thrombectomy are to open blocked blood vessels, relieve symptoms, and stop more problems from developing.

The use of thrombectomy is carefully examined based on the patient's medical history, general health, and the precise type of the blood clot because it poses possible dangers similar to those associated with any medical operation.

GLOBAL THROMBECTOMY CATHETER MARKET SIZE AND FORECAST

The Global Thrombectomy catheter market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.

NEW PRODUCT LAUNCH

The RevCore thrombectomy catheter and the Triever16 Curve catheter are two new, specifically designed products from Inari Medical, Inc. (NASDAQ: NARI), a medical device business with a mission to treat and enhance the lives of patients suffering from venous and other disorders. 

The first mechanical thrombectomy tool, RevCore, was created to treat venous in-stent thrombosis, which affects more patients every year.

The tool has a special diameter-controlled coring component made to safely engage thrombus inside stents. With RevCore, Inari has created a solution for a whole new patient population that the ClotTriever and FlowTriever platforms do not currently serve.

The newest addition to the FlowTriever platform, the Triever16 Curve catheter, was created with the specific intent of being adaptable for both peripheral thrombectomy and pulmonary embolism.

COMPANY PROFILE

• Johnson & Johnson Medical Ltd
• Medtronic Plc
• Wallaby Medical Inc
• Stryker Corp
• Balt SAS

THIS REPORT WILL ANSWER FOLLOWING QUESTIONS

1. How many Thrombectomy catheters are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of a Global Thrombectomy catheter and key vendor selection criteria
3. Where is the Thrombectomy catheter manufactured? What is the average margin per unit?
4. Market share of Global Thrombectomy catheter market manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture Global Thrombectomy catheter in-house
6. key predictions for next 5 years in Global Thrombectomy catheter market
7. Average B-2-B Thrombectomy catheter market price in all segments
8. Latest trends in Thrombectomy catheter market, by every market segment
9. The market size (both volume and value) of the Thrombectomy catheter market in 2023-2030 and every year in between?
10. Production breakup of Thrombectomy catheter market, by suppliers and their OEM relationship